111 related articles for article (PubMed ID: 2043483)
21. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
22. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through a tyrosine kinase-dependent pathway.
Kansas GS; Tedder TF
J Immunol; 1991 Dec; 147(12):4094-102. PubMed ID: 1721639
[TBL] [Abstract][Full Text] [Related]
23. Multiple myeloma: circulating lymphocytes that express plasma cell antigens.
Ruiz-Argüelles GJ; Katzmann JA; Greipp PR; Gonchoroff NJ; Garton JP; Kyle RA
Blood; 1984 Aug; 64(2):352-6. PubMed ID: 6611178
[TBL] [Abstract][Full Text] [Related]
24. Phenotypic and functional characterization of normal and malignant terminal B (plasma) cells.
Anderson KC; Cochran M; Barut BA
Eur J Haematol Suppl; 1989; 51():19-26. PubMed ID: 2627990
[TBL] [Abstract][Full Text] [Related]
25. The role of adhesion molecules in multiple myeloma.
Barker HF; Ball J; Drew M; Hamilton MS; Franklin IM
Leuk Lymphoma; 1992 Oct; 8(3):189-96. PubMed ID: 1490146
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G
Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562
[TBL] [Abstract][Full Text] [Related]
27. [Preliminary study of immunophenotype of multiple myeloma cells].
Wang LL
Zhonghua Zhong Liu Za Zhi; 1993 Jul; 15(4):286-8. PubMed ID: 8174466
[TBL] [Abstract][Full Text] [Related]
28. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
29. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help.
Lederman S; Yellin MJ; Inghirami G; Lee JJ; Knowles DM; Chess L
J Immunol; 1992 Dec; 149(12):3817-26. PubMed ID: 1281189
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. Castellano-Leones (Spain) Cooperative Group for the Study of Monoclonal Gammopathies.
San Miguel JF; González M; Gascón A; Moro MJ; Hernández JM; Ortega F; Jimenez R; Guerras L; Romero M; Casanova F
Br J Haematol; 1991 Feb; 77(2):185-90. PubMed ID: 1706197
[TBL] [Abstract][Full Text] [Related]
31. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization.
Pellat-Deceunynck C; Barillé S; Puthier D; Rapp MJ; Harousseau JL; Bataille R; Amiot M
Cancer Res; 1995 Aug; 55(16):3647-53. PubMed ID: 7543019
[TBL] [Abstract][Full Text] [Related]
32. ZB51: a monoclonal antibody reactive with human plasma cells.
Webster R; Pulford K; Jones M; Micklem K; de Waele M; Mayne K; Tse A; Mason DY
Br J Haematol; 1993 Aug; 84(4):602-7. PubMed ID: 8217816
[TBL] [Abstract][Full Text] [Related]
33. Multiple myeloma: 'early' plasma cell phenotype identifies patients with aggressive biological and clinical characteristics.
Omedè P; Boccadoro M; Fusaro A; Gallone G; Pileri A
Br J Haematol; 1993 Nov; 85(3):504-13. PubMed ID: 8136273
[TBL] [Abstract][Full Text] [Related]
34. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54).
Horst E; Meijer CJ; Radaszkiewicz T; Ossekoppele GJ; Van Krieken JH; Pals ST
Leukemia; 1990 Aug; 4(8):595-9. PubMed ID: 1974938
[TBL] [Abstract][Full Text] [Related]
35. B-cell differentiation antigen expressed on a human myeloma cell line (KMM-1).
Togawa A; Inoue N; Mannoji M; Namba M
Jpn J Clin Oncol; 1983 Sep; 13(3):511-5. PubMed ID: 6417374
[TBL] [Abstract][Full Text] [Related]
36. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
Hooijberg E; van den Berk PC; Sein JJ; Wijdenes J; Hart AA; de Boer RW; Melief CJ; Hekman A
Cancer Res; 1995 Feb; 55(4):840-6. PubMed ID: 7531616
[TBL] [Abstract][Full Text] [Related]
37. A unique human B lymphocyte antigen defined by a monoclonal antibody.
Meeker TC; Miller RA; Link MP; Bindl J; Warnke R; Levy R
Hybridoma; 1984; 3(4):305-20. PubMed ID: 6441771
[TBL] [Abstract][Full Text] [Related]
38. Multiple myeloma: New surface antigens for the characterization of plasma cells in the era of novel agents.
Muccio VE; Saraci E; Gilestro M; Gattei V; Zucchetto A; Astolfi M; Ruggeri M; Marzanati E; Passera R; Palumbo A; Boccadoro M; Omedè P
Cytometry B Clin Cytom; 2016 Jan; 90(1):81-90. PubMed ID: 26287276
[TBL] [Abstract][Full Text] [Related]
39. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
Kimlinger T; Witzig TE
Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
[TBL] [Abstract][Full Text] [Related]
40. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
